EBNEO commentary: Maternal high-dose DHA supplementation and neurodevelopment in infants born before 29 weeks' gestation
Acta Paediatr
.
2023 May;112(5):1126-1127.
doi: 10.1111/apa.16704.
Epub 2023 Feb 14.
Authors
Deeva Vather
1
,
Amy Keir
2
3
4
5
Affiliations
1
Department of Paediatric and Neonatal Medicine, Lyell McEwin Hospital, Adelaide, South Australia, Australia.
2
MedSTAR Kids, SA Ambulance Service, Adelaide, South Australia, Australia.
3
Department of Neonatal Medicine, Women's and Children's Hospital, North Adelaide, South Australia, Australia.
4
SAHMRI Women and Kids, South Australian Health and Medical Institute, North Adelaide, South Australia, Australia.
5
Robinson Research Institute and the Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, Australia.
PMID:
36788750
PMCID:
PMC10952704
DOI:
10.1111/apa.16704
No abstract available
MeSH terms
Dietary Supplements
Docosahexaenoic Acids
Female
Gestational Age
Humans
Infant
Infant, Newborn
Infant, Premature*
Parturition*
Pregnancy
Substances
Docosahexaenoic Acids
Grants and funding
APP1161379/Australian National Health and Medical Research Council